Alcresta Therapeutics

RELIZORB

  1. Home
  2.  / 
  3. B Code
  4.  / RELIZORB – B4105

Manufacturer:

Alcresta Therapeutics

Name:

RELIZORB

HCPCS Code Descriptor:

In-line cartridge containing digestive enzyme(s) for enteral feeding, each

Category:

B Code

HCPCS:

B4105

NDC(s):

62205-0000-20

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Route of Administration:

Route Not Applicable

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

62205-0000-20

Please contact us regarding potential compendia errors/discrepancies

About:

RELIZORB is an Enzyme Replacement Therapy drug manufactured by Alcresta Therapeutics and administered via the Route Not Applicable route of administration. The B Code: B4105 is aligned to the drug RELIZORB.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/19

HCPCS Effective Date:

1/1/19

HCPCS Short Description:

Enzyme cartridge enteral nut

Billing and Coding Guide:

Not Found

Patient Assistance:

http://www.relizorb.com/

RELIZORB - B4105